Article

Nephroprotective effect of Withania somnifera: a dose-dependent study.

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamilnadu, India.
Renal Failure (Impact Factor: 0.94). 01/2009; 31(9):814-21. DOI: 10.3109/08860220903150320
Source: PubMed

ABSTRACT In the present study, we investigated the protective effect of Withania somnifera, an indigenous medicinal herb used in ayurvedic traditional systems for more than 3000 years in India, on gentamicin (GEN)-induced nephrotoxicity. The root extract of three different doses of W. somnifera (viz., 250, 500, and 750 mg/kg) was administered orally to rats for 14 days before GEN treatment and thereafter concurrently with GEN (100 mg/kg) for 8 days. Nephrotoxicity was evident in GEN-treated rats by significant increase in kidney weight, urea, creatinine, urinary protein, and glucose, and significant reduction in body weights and potassium, which was histopathologically confirmed by tubular necrosis. In contrast W. somnifera (500 mg/kg) significantly reversed these changes as evidenced microscopically when compared to other two doses of W. somnifera (250 and 750 mg/kg), and there were no significant changes in the levels of sodium in the experimental animals compared to control. Thus, our results suggested the nephroprotective effect of Withania somnifera, which could be by enhancing antioxidant activity with natural antioxidants and scavenging the free radicals.

2 Bookmarks
 · 
106 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Thepresent investigation was designed to investigate the protective effect of (Beta vulgaris L.) beat root ethanolic extract (BVEE) on gentamicin-induced nephrotoxicity and to elucidate the potential mechanism. Serum specific kidney function parameters (urea, uric acid, total protein, creatinine, and histopathology of kidney tissue)were evaluated to access gentamicin-induced nephrotoxicity. Theoxidative/nitrosative stress (Lipid peroxidation,MDA,NP-SH,Catalase, and nitric oxide levels) was assessed.The inflammatory response (TNF-𝛼, IL-6, MPO, NF-𝜅B (p65), and NF-𝜅B (p65) DNA binding) and apoptotic marker (Caspase-3, Bax, and Bcl- 2) were also evaluated. BVEE (250 and 500mg/kg) treatment along with gentamicin restored/increased the renal endogenous antioxidant status. Gentamicin-induced increased renal inflammatory cytokines (TNF-𝛼 and IL-6), nuclear protein expression of NF-𝜅B (p65), NF-𝜅B-DNA binding activity, myeloperoxidase (MPO) activity, and nitric oxide level were significantly down regulated upon BVEE treatment. In addition, BVEE treatment significantly reduced the amount of cleaved caspase 3 and Bax, protein expression and increased the Bcl-2 protein expression. BVEE treatment also ameliorated the extent of histologic injury and reduced inflammatory infiltration in renal tubules.These findings suggest that BVEE treatment attenuates renal dysfunction and structural damage through the reduction of oxidative stress, inflammation, and apoptosis in the kidney.
    Mediators of Inflammation 01/2014; 2014:12 pages. · 3.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Kidney is an important excretory organ. Its damage can be occurred due to prolonged use and higher doses of drugs, exposure to some chemicals, toxins, or infectious agents. Herbal plants as Ashwagandha (Withania somnifera) may have free radical scavenging activity thereby can be used for the prevention and treatment of kidney damage. Objective:To observe the nephroprotective effect of Ashwagandha (Withania somnifera) root against gentamicin induced nephrotoxicity in Wistar albino rats.Methods:This experimental study was carried out in the Department of Physiology , Sir Salimullah Medical College (SSMC), Dhaka from 1st July 2010 to 30th June 2011.A total number of 35 Wistar albino rats, age ranged from 90 to 120 days, weighing between 150 to 200 grams were included in this study.After acclimatization for 14 days, they were divided into control group (GroupA) and experimental group (Group B). Control group was again subdivided into group A1 (baseline control,consisted of 10 rats) and group A2 (gentamicin treated control group, consisted of 10 rats). Again, experimental group (Group B-Ashwagandha pretreated and gentamicin treated group) consisted of 15 rats. All groups of animals received basal diet for 22 consecutive days.In addition to this, group A2 also received gentamicin subcutaneously (100mg /kg body weight/day) for the last eight (15th to 22nd day) consecutive days. Again, group B received ashwagandha root extract (500mg/kg body weight/ day; orally) for 22 consecutive days and gentamicin subcutaneously (100mg/kg body weight /day) for last eight (15th to 22nd day) days.All the animals were sacrificed on 23rd day. Then blood and kidney sample were collected. Estimation of serum urea, creatinine levels were done by using standard Laboratory kits.The statistical analysis was done by one way ANOVA and Bonferroni test as applicable. Results:The mean serum urea, creatinine levels were significantly (p<0.001) higher in gentamicin treated control group in comparison to those of baseline control. Again, these levels were significantly (p<0.01) lower in ashwagandha pretreated and gentamicin treated group (experimental group) when compared to those of gentamicin treated group (control). Conclusion: Ashwagandha (Withania somnifera) root may have some nephroprotective effect against gentamicin induced nephrotoxicity. Key words: Nephroprotective, Ashwagandha, Gentamicin
    Journal of Bangladesh Society of Physiologist 11/2011; vol 6(no 1).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Regulation of electrolytes and body fluids are essential for maintaining the body homeostasis. Kidney plays an important role for these regulations. Higher doses of drugs, toxins, infectious agents, chemicals etc. can causes kidney damage and ultimately electrolytes disturbances can be occurred. Ashwagandha (Withania somnifera) is an herbal plant may have some role on serum electrolytes balance. Objective: To observe the effects of ashwagandha (Withania somnifera) root on serum electrolytes against gentamicin induced nephrotoxicity in Wistar albino rats. Methods: This experimental study was carried out in the Department of Physiology, Sir Salimullah Medical College (SSMC), Dhaka from 1st July 2010 to 30th June 2011. A total number of 35 Wistar albino rats, age from 90 to 120 days, weighing between 150 to 200 grams were selected for the study. After acclimatization for 14 days, they were divided into control group and experimental group. Control group was again subdivided into baseline control, (10 rats) and gentamicin treated control group, (10 rats). Again, experimental group (gentamicin treated group after ashwagandha treatment) consisted of 15 rats. All groups of animals received basal diet for 22 consecutive days. In addition to this, gentamicin treated control group also received gentamicin subcutaneously (100mg /kg body weight/day) for the last eight (15th to 22nd day) consecutive days. Again, gentamicin treated group after ashwagandha treatment received ashwagandha root extract (500mg/kg body weight/day, orally) for 22 consecutive days and gentamicin subcutaneously (100mg/kg body weight /day) for last eight (15th to 22nd day) days. All the animals were sacrificed on 23rd day. Then blood samples were collected and kidney weight was measured. For assessment of kidney function, some serum electrolyte levels e,g. serum sodium, potassium and chloride ion levels were estimated by ion selective electrode (ISE) electrolyte auto analyzer method, by using Biolyte 2000 auto analyzer . However, body weight and kidney weight of the animals were measured to assess the nephrotoxicity in these groups of animals. All these tests were done in the laboratory of Department of Physiology and Biochemistry, SSMC. Statistical analysis was done by one way ANOVA and Bonferroni tests as applicable. Results: The serum sodium and chloride ion levels were almost similar in all the groups and the differences were not statistically significant. The mean serum levels of potassium ion were significantly (p<0.001) lower in gentamicin treated group and (p<0.05) in gentamicin treated group after ashwagandha treatment in comparison to that of baseline control group. But this level of gentamicin treated group after ashwagandha treatment was significantly (p<0.01) higher than that of gentamicin treated group. Initial body weight was almost similar and no significant difference of this value was observed among the groups. Whereas, the final body weight was significantly (p<0.001) lower in gentamicin treated control group and in gentamicin treated group after ashwagandha treatment than that of baseline control group. Again this level of gentamicin treated group after ashwagandha treatment was significantly (p<0.05) higher in comparison to that of gentamicin treated control group. The kidney weight was significantly (p<0.01) higher in gentamicin treated control group when compared to that of baseline control and gentamicin treated group after ashwagandha treatment. Whereas, kidney weight of gentamicin treated group after ashwagandha treatment and of baseline control group was almost similar and showed no statistically significant difference of this value between this two groups. Conclusion:Ashwagandha (Withania somnifera) root extract may have some role in maintaining some of the serum electrolyte levels within normal limit, which indicates its nephroprotective effects against gentamicin induced toxicity. Key words: Electrolytes, Ashwagandha, Gentamicin
    Journal of Bangladesh Society of Physiologist 06/2012; Vol 7(no 1):29-35.